/
/
/

Brooks Laboratories Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)64.17
Volume (₹)1.11 L
High (₹)70.09
Upper Circuit77.47
Low (₹)64.17
Lower Circuit51.65
Prev Close64.56
52W High (₹)112.40
Price65.49
52W Low (₹)36.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)190.53 Cr
Div. Yield (%)0.00
PE Ratio14.42
Debt to Equity0.06
Price to Book0.90
Book Value41.64
EPS (TTM)4.49
Face Value10.00
ROE (%)22.27

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
BROOKSNSE
LTP
1W Low
1W High
Market cap (₹)
1773.4-4.3 (-0.24%)
1722
1810.40
4,25,150Cr
10037.5+257.5 (2.63%)
9863
10067
2,66,265Cr
4738.5+125.1 (2.71%)
4553
4738.50
1,76,301Cr
2323.8-81.7 (-3.40%)
2252.40
2441.90
1,25,352Cr
1188.1-57.4 (-4.61%)
1182.40
1266.60
1,23,591Cr
1374+22 (1.63%)
1336.70
1376.70
1,14,351Cr
1402+23.1 (1.68%)
1364.60
1402
1,12,474Cr
2537.9+45.1 (1.81%)
2457.90
2540
1,02,315Cr
1705+23.6 (1.40%)
1656.20
1724.60
97,757Cr
2008.6-2.4 (-0.12%)
1988.90
2062.10
92,007Cr
65.49+4.93 (8.14%)
60.73
70.09
191Cr

Key Highlights of Brooks Laboratories Ltd Balance Sheet

Brooks Laboratories Ltd balance sheet discloses shareholders' funds of ₹29.46Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹29.46Cr, and the reserves and surplus of the company is ₹91.39Cr.

The company has its non-current liabilities with total liabilities of ₹146.36Cr as of 2026-03-31.

The current liabilities are ₹21.81Cr as of 2026-03-31. At the same time, current assets are ₹37.42Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹90.53Cr and tangible assets of ₹14.52Cr, provided in the Brooks Laboratories Ltd financial statements.